efficacy safety meriva curcumin-phosphatidylcholine complex extended administration osteoarthritis patients pubmed ncbi abstract previous three-month study meriva proprietary curcumin-phosphatidylcholine phytosome complex decreased joint pain improvement joint function observed num osteoarthritis oa patients oa chronic condition requiring prolonged treatment long-term efficacy safety meriva investigated longer months study involving num oa patients clinical end points western ontario mcmaster universities womac score karnofsky performance scale index treadmill walking performance complemented evaluation series inflammatory markers interleukin il num eta il num soluble cd num ligand scd num soluble vascular cell adhesion molecule svcam num erythrocyte sedimentation rate esr represents ambitious attempt date evaluate clinical efficacy safety curcumin anti-inflammatory agent significant improvements clinical biochemical end points observed meriva compared control group coupled excellent tolerability suggests meriva worth long-term complementary management osteoarthritis 
